Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Hyperimmune Globulins market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Hyperimmune Globulins market. Detailed analysis of key players, along with key growth strategies adopted by Hyperimmune Globulins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
CSL Behring
Grifols
Biotest
CNBG
Shanghai RAAS
Hualan Bio
Sichuan Yuanda Shuyang
Kedrion
Kamada
Emergent (Cangene)
ADMA Biologics
CBPO
By Type:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
By End-User:
Government Institutions
Private Sector
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hyperimmune Globulins Market
-
1.3 Market Segment by Type
-
1.3.1 China Hyperimmune Globulins Market Size and Growth Rate of Hepatitis B Immunoglobulins from 2016 to 2027
-
1.3.2 China Hyperimmune Globulins Market Size and Growth Rate of Rabies Immunoglobulins from 2016 to 2027
-
1.3.3 China Hyperimmune Globulins Market Size and Growth Rate of Tetanus Immunoglobulins from 2016 to 2027
-
1.3.4 China Hyperimmune Globulins Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Hyperimmune Globulins Market Size and Growth Rate of Government Institutions from 2016 to 2027
-
1.4.2 China Hyperimmune Globulins Market Size and Growth Rate of Private Sector from 2016 to 2027
-
1.4.3 China Hyperimmune Globulins Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Hyperimmune Globulins Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hyperimmune Globulins by Major Types
-
3.4.1 Market Size and Growth Rate of Hepatitis B Immunoglobulins
-
3.4.2 Market Size and Growth Rate of Rabies Immunoglobulins
-
3.4.3 Market Size and Growth Rate of Tetanus Immunoglobulins
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Hyperimmune Globulins Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hyperimmune Globulins by Major End-Users
-
4.4.1 Market Size and Growth Rate of Hyperimmune Globulins in Government Institutions
-
4.4.2 Market Size and Growth Rate of Hyperimmune Globulins in Private Sector
-
4.4.3 Market Size and Growth Rate of Hyperimmune Globulins in Other
5 Market Analysis by Regions
-
5.1 China Hyperimmune Globulins Production Analysis by Regions
-
5.2 China Hyperimmune Globulins Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Hyperimmune Globulins Landscape Analysis
-
6.1 North China Hyperimmune Globulins Landscape Analysis by Major Types
-
6.2 North China Hyperimmune Globulins Landscape Analysis by Major End-Users
7 Central China Hyperimmune Globulins Landscape Analysis
-
7.1 Central China Hyperimmune Globulins Landscape Analysis by Major Types
-
7.2 Central China Hyperimmune Globulins Landscape Analysis by Major End-Users
8 South China Hyperimmune Globulins Landscape Analysis
-
8.1 South China Hyperimmune Globulins Landscape Analysis by Major Types
-
8.2 South China Hyperimmune Globulins Landscape Analysis by Major End-Users
9 East China Hyperimmune Globulins Landscape Analysis
-
9.1 East China Hyperimmune Globulins Landscape Analysis by Major Types
-
9.2 East China Hyperimmune Globulins Landscape Analysis by Major End-Users
10 Northeast China Hyperimmune Globulins Landscape Analysis
-
10.1 Northeast China Hyperimmune Globulins Landscape Analysis by Major Types
-
10.2 Northeast China Hyperimmune Globulins Landscape Analysis by Major End-Users
11 Southwest China Hyperimmune Globulins Landscape Analysis
-
11.1 Southwest China Hyperimmune Globulins Landscape Analysis by Major Types
-
11.2 Southwest China Hyperimmune Globulins Landscape Analysis by Major End-Users
12 Northwest China Hyperimmune Globulins Landscape Analysis
-
12.1 Northwest China Hyperimmune Globulins Landscape Analysis by Major Types
-
12.2 Northwest China Hyperimmune Globulins Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 CSL Behring
-
13.1.1 CSL Behring Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Grifols
-
13.2.1 Grifols Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Biotest
-
13.3.1 Biotest Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 CNBG
-
13.4.1 CNBG Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Shanghai RAAS
-
13.5.1 Shanghai RAAS Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Hualan Bio
-
13.6.1 Hualan Bio Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sichuan Yuanda Shuyang
-
13.7.1 Sichuan Yuanda Shuyang Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Kedrion
-
13.8.1 Kedrion Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Kamada
-
13.9.1 Kamada Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Emergent (Cangene)
-
13.10.1 Emergent (Cangene) Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 ADMA Biologics
-
13.11.1 ADMA Biologics Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 CBPO
-
13.12.1 CBPO Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Hepatitis B Immunoglobulins from 2016 to 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Rabies Immunoglobulins from 2016 to 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Tetanus Immunoglobulins from 2016 to 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Government Institutions from 2016 to 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Private Sector from 2016 to 2027
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Hyperimmune Globulins Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Hyperimmune Globulins
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hyperimmune Globulins by Different Types from 2016 to 2027
-
Table Consumption Share of Hyperimmune Globulins by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hepatitis B Immunoglobulins
-
Figure Market Size and Growth Rate of Rabies Immunoglobulins
-
Figure Market Size and Growth Rate of Tetanus Immunoglobulins
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Hyperimmune Globulins by Different End-Users from 2016 to 2027
-
Table Consumption Share of Hyperimmune Globulins by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Government Institutions
-
Figure Market Size and Growth Rate of Private Sector
-
Figure Market Size and Growth Rate of Other
-
Table China Hyperimmune Globulins Production by Regions
-
Table China Hyperimmune Globulins Production Share by Regions
-
Figure China Hyperimmune Globulins Production Share by Regions in 2016
-
Figure China Hyperimmune Globulins Production Share by Regions in 2021
-
Figure China Hyperimmune Globulins Production Share by Regions in 2027
-
Table China Hyperimmune Globulins Consumption by Regions
-
Table China Hyperimmune Globulins Consumption Share by Regions
-
Figure China Hyperimmune Globulins Consumption Share by Regions in 2016
-
Figure China Hyperimmune Globulins Consumption Share by Regions in 2021
-
Figure China Hyperimmune Globulins Consumption Share by Regions in 2027
-
Table North China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table North China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure North China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure North China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure North China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table North China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table North China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure North China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure North China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure North China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Central China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Central China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Central China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Central China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Central China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Central China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Central China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Central China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Central China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table South China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table South China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure South China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure South China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure South China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table South China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table South China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure South China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure South China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure South China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table East China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table East China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure East China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure East China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure East China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table East China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table East China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure East China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure East China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure East China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Northeast China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Northeast China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Northeast China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Northeast China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Northeast China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Northeast China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Northeast China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Northeast China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Southwest China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Southwest China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Southwest China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Southwest China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Southwest China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Southwest China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Southwest China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Southwest China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Northwest China Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Northwest China Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Northwest China Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Northwest China Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Northwest China Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Northwest China Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Northwest China Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Northwest China Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of CSL Behring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring
-
Figure Sales and Growth Rate Analysis of CSL Behring
-
Figure Revenue and Market Share Analysis of CSL Behring
-
Table Product and Service Introduction of CSL Behring
-
Table Company Profile and Development Status of Grifols
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
-
Figure Sales and Growth Rate Analysis of Grifols
-
Figure Revenue and Market Share Analysis of Grifols
-
Table Product and Service Introduction of Grifols
-
Table Company Profile and Development Status of Biotest
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest
-
Figure Sales and Growth Rate Analysis of Biotest
-
Figure Revenue and Market Share Analysis of Biotest
-
Table Product and Service Introduction of Biotest
-
Table Company Profile and Development Status of CNBG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CNBG
-
Figure Sales and Growth Rate Analysis of CNBG
-
Figure Revenue and Market Share Analysis of CNBG
-
Table Product and Service Introduction of CNBG
-
Table Company Profile and Development Status of Shanghai RAAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai RAAS
-
Figure Sales and Growth Rate Analysis of Shanghai RAAS
-
Figure Revenue and Market Share Analysis of Shanghai RAAS
-
Table Product and Service Introduction of Shanghai RAAS
-
Table Company Profile and Development Status of Hualan Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio
-
Figure Sales and Growth Rate Analysis of Hualan Bio
-
Figure Revenue and Market Share Analysis of Hualan Bio
-
Table Product and Service Introduction of Hualan Bio
-
Table Company Profile and Development Status of Sichuan Yuanda Shuyang
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sichuan Yuanda Shuyang
-
Figure Sales and Growth Rate Analysis of Sichuan Yuanda Shuyang
-
Figure Revenue and Market Share Analysis of Sichuan Yuanda Shuyang
-
Table Product and Service Introduction of Sichuan Yuanda Shuyang
-
Table Company Profile and Development Status of Kedrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion
-
Figure Sales and Growth Rate Analysis of Kedrion
-
Figure Revenue and Market Share Analysis of Kedrion
-
Table Product and Service Introduction of Kedrion
-
Table Company Profile and Development Status of Kamada
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada
-
Figure Sales and Growth Rate Analysis of Kamada
-
Figure Revenue and Market Share Analysis of Kamada
-
Table Product and Service Introduction of Kamada
-
Table Company Profile and Development Status of Emergent (Cangene)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent (Cangene)
-
Figure Sales and Growth Rate Analysis of Emergent (Cangene)
-
Figure Revenue and Market Share Analysis of Emergent (Cangene)
-
Table Product and Service Introduction of Emergent (Cangene)
-
Table Company Profile and Development Status of ADMA Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics
-
Figure Sales and Growth Rate Analysis of ADMA Biologics
-
Figure Revenue and Market Share Analysis of ADMA Biologics
-
Table Product and Service Introduction of ADMA Biologics
-
Table Company Profile and Development Status of CBPO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CBPO
-
Figure Sales and Growth Rate Analysis of CBPO
-
Figure Revenue and Market Share Analysis of CBPO
-
Table Product and Service Introduction of CBPO
-
